Population
Ion channels in drug discovery
Comparison
Flux assays for high throughput screening vs Patch clamp data
Design
Review
Authors
Loading...
May accelerate high-throughput ion channel screening; leaves open prospective validation for cardiovascular drug development.
Flux assays, particularly nonradiolabeled rubidium-based assays, offer a high-throughput, automated alternative to patch clamping for ion channel drug discovery.
Gill et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: